Researchers have demonstrated that Nafamostat mesylate (Fusan) can inhibit SARS-CoV-2 Spike protein-initiated membrane fusion at concentrations likely achievable and safe in patients.
List view / Grid view
Filter the results
A study has discovered that a biomarker associated with pancreatitis is involved in its development to pancreatic cancer.
A study has shown that disruption to cell autophagy is involved in the development of pancreatic cancer.